Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
27,461
archived clinical trials in
Hematology

Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
A Randomized Phase II/III Trial of "Novel Therapeutics" Versus Azacitidine in Newly Diagnosed Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS), Age 60 or Older LEAP: Less-Intense AML Platform Trial
Status: Enrolling
Updated:  12/31/1969
Saint Vincent Hospital Cancer Center at Oconto Falls
mi
from
Oconto Falls, WI
Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
A Randomized Phase II/III Trial of "Novel Therapeutics" Versus Azacitidine in Newly Diagnosed Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS), Age 60 or Older LEAP: Less-Intense AML Platform Trial
Status: Enrolling
Updated: 12/31/1969
Saint Vincent Hospital Cancer Center at Oconto Falls
mi
from
Oconto Falls, WI
Click here to add this to my saved trials
Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
A Randomized Phase II/III Trial of "Novel Therapeutics" Versus Azacitidine in Newly Diagnosed Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS), Age 60 or Older LEAP: Less-Intense AML Platform Trial
Status: Enrolling
Updated:  12/31/1969
Parkview Regional Medical Center
mi
from
Fort Wayne, IN
Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
A Randomized Phase II/III Trial of "Novel Therapeutics" Versus Azacitidine in Newly Diagnosed Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS), Age 60 or Older LEAP: Less-Intense AML Platform Trial
Status: Enrolling
Updated: 12/31/1969
Parkview Regional Medical Center
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
A Randomized Phase II/III Trial of "Novel Therapeutics" Versus Azacitidine in Newly Diagnosed Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS), Age 60 or Older LEAP: Less-Intense AML Platform Trial
Status: Enrolling
Updated:  12/31/1969
Edward Hines,Jr., VA Hospital
mi
from
Hines, IL
Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
A Randomized Phase II/III Trial of "Novel Therapeutics" Versus Azacitidine in Newly Diagnosed Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS), Age 60 or Older LEAP: Less-Intense AML Platform Trial
Status: Enrolling
Updated: 12/31/1969
Edward Hines,Jr., VA Hospital
mi
from
Hines, IL
Click here to add this to my saved trials
Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
A Randomized Phase II/III Trial of "Novel Therapeutics" Versus Azacitidine in Newly Diagnosed Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS), Age 60 or Older LEAP: Less-Intense AML Platform Trial
Status: Enrolling
Updated:  12/31/1969
Dayton Physician LLC-Miami Valley Hospital North
mi
from
Dayton, OH
Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
A Randomized Phase II/III Trial of "Novel Therapeutics" Versus Azacitidine in Newly Diagnosed Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS), Age 60 or Older LEAP: Less-Intense AML Platform Trial
Status: Enrolling
Updated: 12/31/1969
Dayton Physician LLC-Miami Valley Hospital North
mi
from
Dayton, OH
Click here to add this to my saved trials
Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
A Randomized Phase II/III Trial of "Novel Therapeutics" Versus Azacitidine in Newly Diagnosed Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS), Age 60 or Older LEAP: Less-Intense AML Platform Trial
Status: Enrolling
Updated:  12/31/1969
Academic Hematology Oncology Specialists
mi
from
Grosse Pointe Woods, MI
Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
A Randomized Phase II/III Trial of "Novel Therapeutics" Versus Azacitidine in Newly Diagnosed Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS), Age 60 or Older LEAP: Less-Intense AML Platform Trial
Status: Enrolling
Updated: 12/31/1969
Academic Hematology Oncology Specialists
mi
from
Grosse Pointe Woods, MI
Click here to add this to my saved trials
Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
A Randomized Phase II/III Trial of "Novel Therapeutics" Versus Azacitidine in Newly Diagnosed Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS), Age 60 or Older LEAP: Less-Intense AML Platform Trial
Status: Enrolling
Updated:  12/31/1969
Ascension Saint Mary's Hospital
mi
from
Saginaw, MI
Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
A Randomized Phase II/III Trial of "Novel Therapeutics" Versus Azacitidine in Newly Diagnosed Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS), Age 60 or Older LEAP: Less-Intense AML Platform Trial
Status: Enrolling
Updated: 12/31/1969
Ascension Saint Mary's Hospital
mi
from
Saginaw, MI
Click here to add this to my saved trials
Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
A Randomized Phase II/III Trial of "Novel Therapeutics" Versus Azacitidine in Newly Diagnosed Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS), Age 60 or Older LEAP: Less-Intense AML Platform Trial
Status: Enrolling
Updated:  12/31/1969
Ascension Saint Joseph Hospital
mi
from
Tawas City, MI
Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
A Randomized Phase II/III Trial of "Novel Therapeutics" Versus Azacitidine in Newly Diagnosed Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS), Age 60 or Older LEAP: Less-Intense AML Platform Trial
Status: Enrolling
Updated: 12/31/1969
Ascension Saint Joseph Hospital
mi
from
Tawas City, MI
Click here to add this to my saved trials
Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
A Randomized Phase II/III Trial of "Novel Therapeutics" Versus Azacitidine in Newly Diagnosed Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS), Age 60 or Older LEAP: Less-Intense AML Platform Trial
Status: Enrolling
Updated:  12/31/1969
Sanford Roger Maris Cancer Center
mi
from
Fargo, ND
Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
A Randomized Phase II/III Trial of "Novel Therapeutics" Versus Azacitidine in Newly Diagnosed Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS), Age 60 or Older LEAP: Less-Intense AML Platform Trial
Status: Enrolling
Updated: 12/31/1969
Sanford Roger Maris Cancer Center
mi
from
Fargo, ND
Click here to add this to my saved trials
Single Arm Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Patients With Atypical Hemolytic Uremic Syndrome (aHUS)
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Site
mi
from
Whittier, CA
Single Arm Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Patients With Atypical Hemolytic Uremic Syndrome (aHUS)
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Site
mi
from
Whittier, CA
Click here to add this to my saved trials
Single Arm Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Patients With Atypical Hemolytic Uremic Syndrome (aHUS)
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Site
mi
from
Fort Wayne, IN
Single Arm Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Patients With Atypical Hemolytic Uremic Syndrome (aHUS)
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Site
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
Single Arm Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Patients With Atypical Hemolytic Uremic Syndrome (aHUS)
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Site
mi
from
Akron, OH
Single Arm Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Patients With Atypical Hemolytic Uremic Syndrome (aHUS)
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Site
mi
from
Akron, OH
Click here to add this to my saved trials
Single Arm Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Patients With Atypical Hemolytic Uremic Syndrome (aHUS)
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Site
mi
from
Columbus, OH
Single Arm Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Patients With Atypical Hemolytic Uremic Syndrome (aHUS)
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Site
mi
from
Columbus, OH
Click here to add this to my saved trials
Single Arm Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Patients With Atypical Hemolytic Uremic Syndrome (aHUS)
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Site
mi
from
Adelaide,
Single Arm Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Patients With Atypical Hemolytic Uremic Syndrome (aHUS)
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Site
mi
from
Adelaide,
Click here to add this to my saved trials
Single Arm Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Patients With Atypical Hemolytic Uremic Syndrome (aHUS)
Status: Enrolling
Updated:  12/31/1969
Clincial Trial Site
mi
from
Durham, NC
Single Arm Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Patients With Atypical Hemolytic Uremic Syndrome (aHUS)
Status: Enrolling
Updated: 12/31/1969
Clincial Trial Site
mi
from
Durham, NC
Click here to add this to my saved trials
Single Arm Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Patients With Atypical Hemolytic Uremic Syndrome (aHUS)
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Site
mi
from
Winston-Salem, NC
Single Arm Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Patients With Atypical Hemolytic Uremic Syndrome (aHUS)
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Site
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
AZD2171 to Treat Children and Adolescents With Solid Tumors or Acute Myelogenous Leukemia
Phase I Trial of CEDIRANIB (AZD2171), an Orally Bioavailable Antiangiogenic Agent, in Children and Adolescents With Refractory or Recurrent Solid Tumors
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
AZD2171 to Treat Children and Adolescents With Solid Tumors or Acute Myelogenous Leukemia
Phase I Trial of CEDIRANIB (AZD2171), an Orally Bioavailable Antiangiogenic Agent, in Children and Adolescents With Refractory or Recurrent Solid Tumors
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated:  12/31/1969
University of Arizona
mi
from
Tucson, AZ
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated: 12/31/1969
University of Arizona
mi
from
Tucson, AZ
Click here to add this to my saved trials
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated:  12/31/1969
University of California Davis
mi
from
Davis, CA
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated: 12/31/1969
University of California Davis
mi
from
Davis, CA
Click here to add this to my saved trials
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Orange County
mi
from
Orange, CA
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Orange County
mi
from
Orange, CA
Click here to add this to my saved trials
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated:  12/31/1969
University of Colorado
mi
from
Denver, CO
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated: 12/31/1969
University of Colorado
mi
from
Denver, CO
Click here to add this to my saved trials
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated:  12/31/1969
Christiana Hospital
mi
from
Wilmington, DE
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated: 12/31/1969
Christiana Hospital
mi
from
Wilmington, DE
Click here to add this to my saved trials
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated:  12/31/1969
Emory University
mi
from
Atlanta, GA
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated: 12/31/1969
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated:  12/31/1969
Univ of Illinois
mi
from
Chicago, IL
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated: 12/31/1969
Univ of Illinois
mi
from
Chicago, IL
Click here to add this to my saved trials
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated:  12/31/1969
Children's Memorial Hospital, Chicago
mi
from
Chicago, IL
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated: 12/31/1969
Children's Memorial Hospital, Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated:  12/31/1969
St. Vincent's Hospital
mi
from
Indianapolis, IN
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated: 12/31/1969
St. Vincent's Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated:  12/31/1969
Tulane University
mi
from
New Orleans, LA
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated: 12/31/1969
Tulane University
mi
from
New Orleans, LA
Click here to add this to my saved trials
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated:  12/31/1969
Wayne State University - Hutzel Hospital
mi
from
Detroit, MI
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated: 12/31/1969
Wayne State University - Hutzel Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated:  12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated: 12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated:  12/31/1969
University of Mississippi
mi
from
Jackson, MS
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated: 12/31/1969
University of Mississippi
mi
from
Jackson, MS
Click here to add this to my saved trials
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated:  12/31/1969
St. Louis University
mi
from
Saint Louis, MO
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated: 12/31/1969
St. Louis University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated:  12/31/1969
University of New Mexico
mi
from
Albuquerque, NM
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated: 12/31/1969
University of New Mexico
mi
from
Albuquerque, NM
Click here to add this to my saved trials
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated:  12/31/1969
University at Buffalo
mi
from
Buffalo, NY
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated: 12/31/1969
University at Buffalo
mi
from
Buffalo, NY
Click here to add this to my saved trials
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated:  12/31/1969
North Shore - Long Island Jewish Health System
mi
from
Lake Success, NY
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated: 12/31/1969
North Shore - Long Island Jewish Health System
mi
from
Lake Success, NY
Click here to add this to my saved trials
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated:  12/31/1969
Cornell University
mi
from
New York, NY
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated: 12/31/1969
Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated:  12/31/1969
Mt. Sinai Medical Center
mi
from
New York, NY
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated: 12/31/1969
Mt. Sinai Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated:  12/31/1969
Univ of North Carolina
mi
from
Chapel Hill, NC
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated: 12/31/1969
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated:  12/31/1969
Wake Forest University
mi
from
Winston-Salem, NC
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated: 12/31/1969
Wake Forest University
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated:  12/31/1969
Childrens Hospital, Cinncinati
mi
from
Cincinnati, OH
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated: 12/31/1969
Childrens Hospital, Cinncinati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated:  12/31/1969
University of Cincinnati
mi
from
Cincinnati, OH
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated: 12/31/1969
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated:  12/31/1969
Ohio State University
mi
from
Columbus, OH
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated: 12/31/1969
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated:  12/31/1969
Wright State University
mi
from
Dayton, OH
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated: 12/31/1969
Wright State University
mi
from
Dayton, OH
Click here to add this to my saved trials
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated:  12/31/1969
University of Oklahoma
mi
from
Oklahoma City, OK
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated: 12/31/1969
University of Oklahoma
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated:  12/31/1969
Milton Hershey Medical Center
mi
from
Hershey, PA
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated: 12/31/1969
Milton Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated:  12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated:  12/31/1969
Thomas Jefferson University
mi
from
Philadelphia, PA
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated: 12/31/1969
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated:  12/31/1969
Palmentto Health Alliance
mi
from
Columbia, SC
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated: 12/31/1969
Palmentto Health Alliance
mi
from
Columbia, SC
Click here to add this to my saved trials
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated:  12/31/1969
University of Tennessee
mi
from
Memphis, TN
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated: 12/31/1969
University of Tennessee
mi
from
Memphis, TN
Click here to add this to my saved trials
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University
mi
from
Nashville, TN
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated:  12/31/1969
The University of Texas, Houston
mi
from
Houston, TX
The Second Multicenter Hemophilia Cohort Study
The Second Multicenter Hemophilia Cohort Study
Status: Enrolling
Updated: 12/31/1969
The University of Texas, Houston
mi
from
Houston, TX
Click here to add this to my saved trials